NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CEO George Lawrence Mikan III sold 16,803 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $4.18, for a total value of $70,236.54. Following the sale, the chief executive officer now owns 83,029 shares of the company’s stock, valued at approximately $347,061.22. This represents a 16.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
NeueHealth Stock Performance
NYSE:NEUE traded up $0.01 during mid-day trading on Wednesday, reaching $4.06. 8,840 shares of the company’s stock were exchanged, compared to its average volume of 17,533. The firm has a market capitalization of $33.64 million, a PE ratio of -0.08 and a beta of 0.78. NeueHealth, Inc. has a one year low of $3.99 and a one year high of $16.59. The business’s fifty day simple moving average is $5.15 and its two-hundred day simple moving average is $5.26.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the business. NEA Management Company LLC acquired a new stake in NeueHealth during the second quarter worth approximately $14,834,000. Deer Management Co. LLC bought a new stake in shares of NeueHealth during the 2nd quarter valued at $5,436,000. Partners Group Holding AG acquired a new stake in shares of NeueHealth during the 3rd quarter worth $463,000. Renaissance Technologies LLC bought a new position in shares of NeueHealth in the second quarter worth $312,000. Finally, Pathway Capital Management LP acquired a new position in NeueHealth in the second quarter valued at about $61,000. 63.88% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Recommended Stories
- Five stocks we like better than NeueHealth
- Stock Market Upgrades: What Are They?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.